Image

Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy

Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

The objective is to investigate the safety and effectiveness of rhomboid intercostal and subserratum plane (RISS) block for postoperative analgesia after minimally invasive McKeown esophagectomy (MIE-McKeown).

Description

Rhomboid intercostal and subserratum plane block (RISS) is a nerve block technique in which local anesthetics are injected into the rhomboid-intercostal muscle planes and the serratus anterius-intercostal muscle planes, and the intercostal nerve is blocked by diffusion of local anesthetics. It is confirmed that RISS can provide analgesia not only in the front half of the chest, but also in the upper abdomen. However, the efficacy of RISS in minimally invasive surgery for esophageal cancer has not been proven. The investigators placed catheters on the RISS plane and continuously injected local anesthetics to investigate whether RISS is effective and safe in minimally invasive esophageal cancer surgery.

Eligibility

Inclusion Criteria:

  • Patients received MIE-McKeown surgery and were confirmed by postoperative pathology; Age 18-75 years old
  • body mass index (BMI) : 18.5~23.9kg/m2;
  • American Society of Anesthesiologists (ASA) grade: Ⅰ~Ⅱ;
  • Clear consciousness, no cognitive impairment;
  • Patients informed to participate in the study and signed informed consent.

Exclusion Criteria:

  • Infection of the puncture site, abnormal platelet or coagulation function;
  • Patients with drug allergy involved in this study;
  • Long-term use of analgesic, sedative drugs or a history of heavy drinking;
  • Patients with chronic painful diseases;
  • With severe heart, liver, kidney and lung dysfunction;
  • Infectious diseases, blood, immune, circulatory system diseases; -Communication barriers, can not cooperate with the scale assessment; -
  • Other situations not suitable for this study.

Study details
    Esophagus Cancer

NCT06092944

Luo Fuchao

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.